Department of Medical Biochemistry and Pharmacology, Haukeland University Hospital, Bergen, Norway.
Centre for Clinical Research, Haukeland University Hospital, Bergen, Norway.
Immun Inflamm Dis. 2023 Jan;11(1):e751. doi: 10.1002/iid3.751.
It is important and expected of laboratories to provide updated reference intervals to the clinician. As no recent publications report adult total IgE reference intervals on a Scandinavian population, the aim of our study was therefore to provide an estimate on healthy Norweigian adults.
A reference interval study was conducted in accordance to CLSI guidelines. Samples were collected from n = 252 presumably healthy adult participants enrolled through the regional blood donation program. Total IgE measurements were performed on the ImmunoCAP platform (Thermo Fisher Diagnostics) traceable to the WHO-reference standard (75/502) for total IgE measurements.
An upper 95% total IgE reference limit was estimated to 302 kU/L (90% CI 177-388 kU/L), and the 97.5% percentile was estimated to 391 kU/L (90% CI 344-560 kU/L). No significant differences were found between participants who self-reported having an allergic disease and participants who did not self-report having an allergic disease.
Our results and other recent publications find markedly higher values than adult reference intervals established four decades ago which still remain widely used by clinical laboratories. We therefore recommend total IgE reference intervals should be critically reviewed and updated.
实验室向临床医生提供最新的参考区间非常重要,也是临床医生所期望的。由于没有最近的出版物报告斯堪的纳维亚人群的成人总 IgE 参考区间,因此我们的研究目的是为健康的挪威成年人提供估计值。
根据 CLSI 指南进行了参考区间研究。通过区域献血计划招募了 n=252 名假定健康的成年参与者,采集了样本。总 IgE 测量在 ImmunoCAP 平台(赛默飞世尔诊断)上进行,该平台可追溯至总 IgE 测量的世界卫生组织参考标准(75/502)。
估计上 95%的总 IgE 参考上限为 302 kU/L(90%CI 177-388 kU/L),97.5%的百分位数估计为 391 kU/L(90%CI 344-560 kU/L)。自我报告有过敏疾病的参与者和没有自我报告有过敏疾病的参与者之间没有发现显著差异。
我们的结果和其他最近的出版物发现,与四十年前建立的成人参考区间相比,数值明显更高,而这些参考区间仍然被临床实验室广泛使用。因此,我们建议应严格审查和更新总 IgE 参考区间。